{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T08:54:12Z","timestamp":1780649652703,"version":"3.54.1"},"reference-count":108,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2024,11,21]],"date-time":"2024-11-21T00:00:00Z","timestamp":1732147200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,11,21]],"date-time":"2024-11-21T00:00:00Z","timestamp":1732147200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pituitary"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1007\/s11102-024-01468-y","type":"journal-article","created":{"date-parts":[[2024,11,21]],"date-time":"2024-11-21T00:32:52Z","timestamp":1732149172000},"page":"813-823","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Novel approach to bone comorbidity in resistant acromegaly"],"prefix":"10.1007","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1308-5598","authenticated-orcid":false,"given":"Stefano","family":"Frara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Acanfora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Franzese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8741-0592","authenticated-orcid":false,"given":"Maria Luisa","family":"Brandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7810-8247","authenticated-orcid":false,"given":"Marco","family":"Losa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6783-3398","authenticated-orcid":false,"given":"Andrea","family":"Giustina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,21]]},"reference":[{"issue":"1","key":"1468_CR1","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1038\/s41572-019-0071-6","volume":"5","author":"A Colao","year":"2019","unstructured":"Colao A, Grasso LFS, Giustina A, Melmed S, Chanson P, Pereira AM, Pivonello R (2019) Acromegaly. Nat Rev Dis Primers 5(1):20. https:\/\/doi.org\/10.1038\/s41572-019-0071-6","journal-title":"Nat Rev Dis Primers"},{"issue":"6","key":"1468_CR2","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1210\/endrev\/bnac010","volume":"43","author":"S Melmed","year":"2022","unstructured":"Melmed S, Kaiser UB, Lopes MB, Bertherat J, Syro LV, Raverot G, Reincke M, Johannsson G, Beckers A, Fleseriu M, Giustina A, Wass JAH, Ho KKY (2022) Clinical Biology of the Pituitary Adenoma. Endocr Rev 43(6):1003\u20131037. https:\/\/doi.org\/10.1210\/endrev\/bnac010","journal-title":"Endocr Rev"},{"issue":"15","key":"1468_CR3","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1016\/s0002-9149(99)80721-8","volume":"75","author":"A Giustina","year":"1995","unstructured":"Giustina A, Boni E, Romanelli G, Grassi V, Giustina G (1995) Cardiopulmonary performance during exercise in acromegaly, and the effects of acute suppression of growth hormone hypersecretion with octreotide. Am J Cardiol 75(15):1042\u20131047. https:\/\/doi.org\/10.1016\/s0002-9149(99)80721-8","journal-title":"Am J Cardiol"},{"key":"1468_CR4","doi-asserted-by":"publisher","unstructured":"Giustina A, Barkan A, Beckers A, Biermasz N, Biller BMK, Boguszewski C, Bolanowski M, Bonert V, Bronstein MD, Casanueva FF, Clemmons D, Colao A, Ferone D, Fleseriu M, Frara S, Gadelha MR, Ghigo E, Gurnell M, Heaney AP, Ho K, Ioachimescu A, Katznelson L, Kelestimur F, Kopchick J, Krsek M, Lamberts S, Losa M, Luger A, Maffei P, Marazuela M, Mazziotti G, Mercado M, Mortini P, Neggers S, Pereira AM, Petersenn S, Puig-Domingo M, Salvatori R, Shimon I, Strasburger C, Tsagarakis S, van der Lely AJ, Wass J, Zatelli MC, Melmed S (2020) A Consensus on the diagnosis and treatment of Acromegaly comorbidities: an update. J Clin Endocrinol Metab 105(4). https:\/\/doi.org\/10.1210\/clinem\/dgz096","DOI":"10.1210\/clinem\/dgz096"},{"issue":"6","key":"1468_CR5","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1530\/EJE-20-0019","volume":"182","author":"D Esposito","year":"2020","unstructured":"Esposito D, Ragnarsson O, Johannsson G, Olsson DS (2020) Prolonged diagnostic delay in acromegaly is associated with increased morbidity and mortality. Eur J Endocrinol\/Eur Fed Endocr Soc 182(6):523\u2013531. https:\/\/doi.org\/10.1530\/EJE-20-0019","journal-title":"Eur J Endocrinol\/Eur Fed Endocr Soc"},{"issue":"1","key":"1468_CR6","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s11102-023-01360-1","volume":"27","author":"A Giustina","year":"2024","unstructured":"Giustina A, Biermasz N, Casanueva FF, Fleseriu M, Mortini P, Strasburger C, van der Lely AJ, Wass J, Melmed S (2024) Consensus on criteria for acromegaly diagnosis and remission. Pituitary 27(1):7\u201322. https:\/\/doi.org\/10.1007\/s11102-023-01360-1","journal-title":"Pituitary"},{"issue":"5","key":"1468_CR7","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1530\/EJE-08-0442","volume":"159","author":"MV Davi","year":"2008","unstructured":"Davi MV, Dalle Carbonare L, Giustina A, Ferrari M, Frigo A, Lo Cascio V, Francia G (2008) Sleep apnoea syndrome is highly prevalent in acromegaly and only partially reversible after biochemical control of the disease. Eur J Endocrinol\/Eur Fed Endocr Soc 159(5):533\u2013540. https:\/\/doi.org\/10.1530\/EJE-08-0442","journal-title":"Eur J Endocrinol\/Eur Fed Endocr Soc"},{"issue":"3","key":"1468_CR8","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1007\/s12020-014-0521-6","volume":"49","author":"S Vandeva","year":"2015","unstructured":"Vandeva S, Yaneva M, Natchev E, Elenkova A, Kalinov K, Zacharieva S (2015) Disease control and treatment modalities have impact on quality of life in acromegaly evaluated by Acromegaly Quality of Life (AcroQoL) Questionnaire. Endocrine 49(3):774\u2013782. https:\/\/doi.org\/10.1007\/s12020-014-0521-6","journal-title":"Endocrine"},{"issue":"1","key":"1468_CR9","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/s11102-016-0761-y","volume":"20","author":"I Crespo","year":"2017","unstructured":"Crespo I, Valassi E, Webb SM (2017) Update on quality of life in patients with acromegaly. Pituitary 20(1):185\u2013188. https:\/\/doi.org\/10.1007\/s11102-016-0761-y","journal-title":"Pituitary"},{"issue":"1","key":"1468_CR10","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s11102-016-0758-6","volume":"20","author":"G Mazziotti","year":"2017","unstructured":"Mazziotti G, Maffezzoni F, Frara S, Giustina A (2017) Acromegalic osteopathy. Pituitary 20(1):63\u201369. https:\/\/doi.org\/10.1007\/s11102-016-0758-6","journal-title":"Pituitary"},{"issue":"4","key":"1468_CR11","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1210\/er.2018-00005","volume":"39","author":"G Mazziotti","year":"2018","unstructured":"Mazziotti G, Frara S, Giustina A (2018) Pituitary diseases and Bone. Endocr Rev 39(4):440\u2013488. https:\/\/doi.org\/10.1210\/er.2018-00005","journal-title":"Endocr Rev"},{"issue":"5","key":"1468_CR12","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1210\/er.2007-0036","volume":"29","author":"A Giustina","year":"2008","unstructured":"Giustina A, Mazziotti G, Canalis E (2008) Growth hormone, insulin-like growth factors, and the skeleton. Endocr Rev 29(5):535\u2013559. https:\/\/doi.org\/10.1210\/er.2007-0036","journal-title":"Endocr Rev"},{"issue":"1","key":"1468_CR13","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1210\/jcem.80.1.7829600","volume":"80","author":"A Giustina","year":"1995","unstructured":"Giustina A, Bussi AR, Jacobello C, Wehrenberg WB (1995) Effects of recombinant human growth hormone (GH) on bone and intermediary metabolism in patients receiving chronic glucocorticoid treatment with suppressed endogenous GH response to GH-releasing hormone. J Clin Endocrinol Metab 80(1):122\u2013129. https:\/\/doi.org\/10.1210\/jcem.80.1.7829600","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"1468_CR14","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1056\/NEJMra067395","volume":"357","author":"E Canalis","year":"2007","unstructured":"Canalis E, Giustina A, Bilezikian JP (2007) Mechanisms of anabolic therapies for osteoporosis. N Engl J Med 357(9):905\u2013916. https:\/\/doi.org\/10.1056\/NEJMra067395","journal-title":"N Engl J Med"},{"issue":"5","key":"1468_CR15","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1530\/eje.1.02285","volume":"155","author":"T Ueland","year":"2006","unstructured":"Ueland T, Fougner SL, Godang K, Schreiner T, Bollerslev J (2006) Serum GH and IGF-I are significant determinants of bone turnover but not bone mineral density in active acromegaly: a prospective study of more than 70 consecutive patients. Eur J Endocrinol\/Eur Fed Endocr Soc 155(5):709\u2013715. https:\/\/doi.org\/10.1530\/eje.1.02285","journal-title":"Eur J Endocrinol\/Eur Fed Endocr Soc"},{"issue":"10","key":"1468_CR16","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1007\/s40618-020-01269-7","volume":"43","author":"P Szulc","year":"2020","unstructured":"Szulc P (2020) Biochemical bone turnover markers in hormonal disorders in adults: a narrative review. J Endocrinol Invest 43(10):1409\u20131427. https:\/\/doi.org\/10.1007\/s40618-020-01269-7","journal-title":"J Endocrinol Investig"},{"issue":"2","key":"1468_CR17","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1210\/jc.2014-2937","volume":"100","author":"G Mazziotti","year":"2015","unstructured":"Mazziotti G, Biagioli E, Maffezzoni F, Spinello M, Serra V, Maroldi R, Floriani I, Giustina A (2015) Bone turnover, bone mineral density, and fracture risk in acromegaly: a meta-analysis. J Clin Endocrinol Metab 100(2):384\u2013394. https:\/\/doi.org\/10.1210\/jc.2014-2937","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"1468_CR18","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.tem.2014.10.005","volume":"26","author":"G Mazziotti","year":"2015","unstructured":"Mazziotti G, Marzullo P, Doga M, Aimaretti G, Giustina A (2015) Growth hormone deficiency in treated acromegaly. Trends Endocrinol Metab 26(1):11\u201321. https:\/\/doi.org\/10.1016\/j.tem.2014.10.005","journal-title":"Trends Endocrinol Metab"},{"issue":"2","key":"1468_CR19","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/s00223-022-01020-9","volume":"112","author":"AS Dincel","year":"2023","unstructured":"Dincel AS, Jorgensen NR, Metabolism I-IJCoB (2023) New Emerging biomarkers for bone disease: Sclerostin and Dickkopf-1 (DKK1). Calcif Tissue Int 112(2):243\u2013257. https:\/\/doi.org\/10.1007\/s00223-022-01020-9","journal-title":"Calcif Tissue Int"},{"issue":"9","key":"1468_CR20","doi-asserted-by":"publisher","first-page":"2690","DOI":"10.1210\/clinem\/dgab260","volume":"106","author":"PPB Silva","year":"2021","unstructured":"Silva PPB, Pereira RMR, Takayama L, Borba CG, Duarte FH, Trarbach EB, Martin RM, Bronstein MD, Tritos NA, Jallad RS (2021) Impaired bone microarchitecture in Premenopausal Women with Acromegaly: the possible role of wnt signaling. J Clin Endocrinol Metab 106(9):2690\u20132706. https:\/\/doi.org\/10.1210\/clinem\/dgab260","journal-title":"J Clin Endocrinol Metab"},{"key":"1468_CR21","doi-asserted-by":"publisher","unstructured":"Pekkolay Z, Kilinc F, Gozel N, Onalan E, Tuzcu AK (2020) Increased serum sclerostin levels in patients with active acromegaly. J Clin Endocrinol Metab 105(3). https:\/\/doi.org\/10.1210\/clinem\/dgz254","DOI":"10.1210\/clinem\/dgz254"},{"issue":"5","key":"1468_CR22","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/j.eprac.2022.01.011","volume":"28","author":"H Chen","year":"2022","unstructured":"Chen H, Huang H, Wang Y, Zhang Y, Liu M, Lou Y, Zhang Z, Zhu D, Li P (2022) Decreased serum wnt antagonist levels in patients with active acromegaly. Endocr Practice: Official J Am Coll Endocrinol Am Association Clin Endocrinologists 28(5):515\u2013520. https:\/\/doi.org\/10.1016\/j.eprac.2022.01.011","journal-title":"Endocr Practice: Official J Am Coll Endocrinol Am Association Clin Endocrinologists"},{"issue":"3","key":"1468_CR23","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1007\/s12020-021-02751-9","volume":"73","author":"MM Uygur","year":"2021","unstructured":"Uygur MM, Yazici DD, Bugdayci O, Yavuz DG (2021) Prevalence of vertebral fractures and serum sclerostin levels in acromegaly. Endocrine 73(3):667\u2013673. https:\/\/doi.org\/10.1007\/s12020-021-02751-9","journal-title":"Endocrine"},{"issue":"1","key":"1468_CR24","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1007\/s12020-021-02850-7","volume":"75","author":"K Claessen","year":"2022","unstructured":"Claessen K, Pelsma ICM, Kroon HM, van Lierop AH, Pereira AM, Biermasz NR, Appelman-Dijkstra NM (2022) Low sclerostin levels after long-term remission of acromegaly. Endocrine 75(1):228\u2013238. https:\/\/doi.org\/10.1007\/s12020-021-02850-7","journal-title":"Endocrine"},{"issue":"4","key":"1468_CR25","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1530\/EJE-17-0772","volume":"178","author":"Z Belaya","year":"2018","unstructured":"Belaya Z, Grebennikova T, Melnichenko G, Nikitin A, Solodovnikov A, Brovkina O, Grigoriev A, Rozhinskaya L, Lutsenko A, Dedov I (2018) Effects of active acromegaly on bone mRNA and microRNA expression patterns. Eur J Endocrinol\/Eur Fed Endocr Soc 178(4):353\u2013364. https:\/\/doi.org\/10.1530\/EJE-17-0772","journal-title":"Eur J Endocrinol\/Eur Fed Endocr Soc"},{"issue":"2","key":"1468_CR26","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1210\/er.2013-1071","volume":"35","author":"P Kamenicky","year":"2014","unstructured":"Kamenicky P, Mazziotti G, Lombes M, Giustina A, Chanson P (2014) Growth hormone, insulin-like growth factor-1, and the kidney: pathophysiological and clinical implications. Endocr Rev 35(2):234\u2013281. https:\/\/doi.org\/10.1210\/er.2013-1071","journal-title":"Endocr Rev"},{"issue":"7","key":"1468_CR27","doi-asserted-by":"publisher","first-page":"2416","DOI":"10.1210\/jc.2016-3693","volume":"102","author":"T Constantin","year":"2017","unstructured":"Constantin T, Tangpricha V, Shah R, Oyesiku NM, Ioachimescu OC, Ritchie J, Ioachimescu AG (2017) Calcium and bone turnover markers in Acromegaly: a prospective, controlled study. J Clin Endocrinol Metab 102(7):2416\u20132424. https:\/\/doi.org\/10.1210\/jc.2016-3693","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"1468_CR28","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1038\/s41574-023-00942-0","volume":"20","author":"A Giustina","year":"2024","unstructured":"Giustina A, Lazaretti-Castro M, Martineau AR, Mason RS, Rosen CJ, Schoenmakers I (2024) A view on vitamin D: a pleiotropic factor? Nat Rev Endocrinol 20(4):202\u2013208. https:\/\/doi.org\/10.1038\/s41574-023-00942-0","journal-title":"Nat Rev Endocrinol"},{"issue":"4","key":"1468_CR29","doi-asserted-by":"publisher","first-page":"e239","DOI":"10.1016\/S2666-7568(24)00032-1","volume":"5","author":"A Giustina","year":"2024","unstructured":"Giustina A (2024) Vitamin D at the crossroad of prediabetes, Sarcopenia, and risk of falls. Lancet Healthy Longev 5(4):e239\u2013e240. https:\/\/doi.org\/10.1016\/S2666-7568(24)00032-1","journal-title":"Lancet Healthy Longev"},{"issue":"2","key":"1468_CR30","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1007\/s12020-022-02994-0","volume":"76","author":"AA Povaliaeva","year":"2022","unstructured":"Povaliaeva AA, Bogdanov VP, Zhukov AY, Pigarova EA, Dzeranova LK, Rozhinskaya LY, Mel\u2019nichenko GA, Mokrysheva NG (2022) Characterization of vitamin D metabolism in active acromegaly in the setting of bolus (150,000 IU) cholecalciferol treatment. Endocrine 76(2):407\u2013418. https:\/\/doi.org\/10.1007\/s12020-022-02994-0","journal-title":"Endocrine"},{"key":"1468_CR31","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-024-03784-6","author":"L di Filippo","year":"2024","unstructured":"di Filippo L, Bilezikian JP, Canalis E, Terenzi U, Giustina A (2024) New insights into the vitamin D\/PTH axis in endocrine-driven metabolic bone diseases. Endocrine. https:\/\/doi.org\/10.1007\/s12020-024-03784-6","journal-title":"Endocrine"},{"issue":"2","key":"1468_CR32","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/s12020-016-0890-0","volume":"52","author":"G Mazziotti","year":"2016","unstructured":"Mazziotti G, Maffezzoni F, Giustina A (2016) Vitamin D-binding protein: one more piece in the puzzle of acromegalic. Osteopathy? Endocr 52(2):183\u2013186. https:\/\/doi.org\/10.1007\/s12020-016-0890-0","journal-title":"Osteopathy? Endocr"},{"issue":"2","key":"1468_CR33","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1530\/eje.1.01841","volume":"152","author":"S Bonadonna","year":"2005","unstructured":"Bonadonna S, Burattin A, Nuzzo M, Bugari G, Rosei EA, Valle D, Iori N, Bilezikian JP, Veldhuis JD, Giustina A (2005) Chronic glucocorticoid treatment alters spontaneous pulsatile parathyroid hormone secretory dynamics in human subjects. Eur J Endocrinol\/Eur Fed Endocr Soc 152(2):199\u2013205. https:\/\/doi.org\/10.1530\/eje.1.01841","journal-title":"Eur J Endocrinol\/Eur Fed Endocr Soc"},{"issue":"6","key":"1468_CR34","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1016\/j.metabol.2006.01.009","volume":"55","author":"G Mazziotti","year":"2006","unstructured":"Mazziotti G, Cimino V, De Menis E, Bonadonna S, Bugari G, De Marinis L, Veldhuis JD, Giustina A (2006) Active acromegaly enhances spontaneous parathyroid hormone pulsatility. Metabolism 55(6):736\u2013740. https:\/\/doi.org\/10.1016\/j.metabol.2006.01.009","journal-title":"Metabolism"},{"issue":"4","key":"1468_CR35","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.tem.2020.01.011","volume":"31","author":"A Giustina","year":"2020","unstructured":"Giustina A (2020) Acromegaly and vertebral fractures: facts and questions. Trends Endocrinol Metab 31(4):274\u2013275. https:\/\/doi.org\/10.1016\/j.tem.2020.01.011","journal-title":"Trends Endocrinol Metab"},{"issue":"2","key":"1468_CR36","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/s00198-003-1531-z","volume":"15","author":"P Vestergaard","year":"2004","unstructured":"Vestergaard P, Mosekilde L (2004) Fracture risk is decreased in acromegaly\u2013a potential beneficial effect of growth hormone. Osteoporos Int 15(2):155\u2013159. https:\/\/doi.org\/10.1007\/s00198-003-1531-z","journal-title":"Osteoporos Int"},{"issue":"4","key":"1468_CR37","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.tem.2023.01.006","volume":"34","author":"MM Uygur","year":"2023","unstructured":"Uygur MM, Frara S, di Filippo L, Giustina A (2023) New tools for bone health assessment in secreting pituitary adenomas. Trends Endocrinol Metab 34(4):231\u2013242. https:\/\/doi.org\/10.1016\/j.tem.2023.01.006","journal-title":"Trends Endocrinol Metab"},{"issue":"7","key":"1468_CR38","doi-asserted-by":"publisher","first-page":"e2843","DOI":"10.1210\/clinem\/dgac183","volume":"107","author":"S Frara","year":"2022","unstructured":"Frara S, Melin Uygur M, di Filippo L, Doga M, Losa M, Santoro S, Mortini P, Giustina A (2022) High prevalence of vertebral fractures Associated with preoperative GH levels in patients with recent diagnosis of Acromegaly. J Clin Endocrinol Metab 107(7):e2843\u2013e2850. https:\/\/doi.org\/10.1210\/clinem\/dgac183","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"1468_CR39","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1007\/s11102-022-01266-4","volume":"25","author":"S Chiloiro","year":"2022","unstructured":"Chiloiro S, Giampietro A, Gagliardi I, Bondanelli M, Veleno M, Ambrosio MR, Zatelli MC, Pontecorvi A, Giustina A, De Marinis L, Bianchi A (2022) Impact of the diagnostic delay of acromegaly on bone health: data from a real life and long term follow-up experience. Pituitary 25(6):831\u2013841. https:\/\/doi.org\/10.1007\/s11102-022-01266-4","journal-title":"Pituitary"},{"key":"1468_CR40","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2024.1414101","author":"S Chiloiro","year":"2024","unstructured":"Chiloiro S, Costanza F, Giampietro A, Infante A, Mattogno PP, Angelini F, Gull\u00ec C, Lauretti L, Rigante M, Olivi A, De Marinis L, Doglietto F, Bianchi A, Pontecorvi A (2024) GH receptor polymorphisms second-line therapies to prevent acromegalskeletal fragility: preliminary results of a pilot study. Front Endocrinol (Lausanne) 15:1414101. https:\/\/doi.org\/10.3389\/fendo.2024.1414101","journal-title":"Front Endocrinol (Lausanne)."},{"issue":"8","key":"1468_CR41","doi-asserted-by":"publisher","first-page":"3402","DOI":"10.1210\/jc.2013-1460","volume":"98","author":"G Mazziotti","year":"2013","unstructured":"Mazziotti G, Bianchi A, Porcelli T, Mormando M, Maffezzoni F, Cristiano A, Giampietro A, De Marinis L, Giustina A (2013) Vertebral fractures in patients with acromegaly: a 3-year prospective study. J Clin Endocrinol Metab 98(8):3402\u20133410. https:\/\/doi.org\/10.1210\/jc.2013-1460","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"1468_CR42","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1016\/j.tem.2016.04.014","volume":"27","author":"S Frara","year":"2016","unstructured":"Frara S, Maffezzoni F, Mazziotti G, Giustina A (2016) Current and emerging aspects of diabetes Mellitus in Acromegaly. Trends Endocrinol Metab 27(7):470\u2013483. https:\/\/doi.org\/10.1016\/j.tem.2016.04.014","journal-title":"Trends Endocrinol Metab"},{"key":"1468_CR43","doi-asserted-by":"publisher","unstructured":"Nardone I, Antonelli R, Zaccaria S, Wolde Sellasie S, Falcone S, Pecchioli C, Giurato L, Uccioli L (2024) Prevalence of diabetes Mellitus and Clinical differences in patients with severe osteoporosis and fragility fractures. J Clin Med 13(9). https:\/\/doi.org\/10.3390\/jcm13092670","DOI":"10.3390\/jcm13092670"},{"issue":"1","key":"1468_CR44","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1007\/s12020-011-9570-2","volume":"41","author":"G Mazziotti","year":"2012","unstructured":"Mazziotti G, Bilezikian J, Canalis E, Cocchi D, Giustina A (2012) New understanding and treatments for osteoporosis. Endocrine 41(1):58\u201369. https:\/\/doi.org\/10.1007\/s12020-011-9570-2","journal-title":"Endocrine"},{"issue":"1","key":"1468_CR45","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1007\/s12020-011-9486-x","volume":"40","author":"G Mazziotti","year":"2011","unstructured":"Mazziotti G, Gola M, Bianchi A, Porcelli T, Giampietro A, Cimino V, Doga M, Gazzaruso C, De Marinis L, Giustina A (2011) Influence of diabetes mellitus on vertebral fractures in men with acromegaly. Endocrine 40(1):102\u2013108. https:\/\/doi.org\/10.1007\/s12020-011-9486-x","journal-title":"Endocrine"},{"issue":"12","key":"1468_CR46","doi-asserted-by":"publisher","first-page":"e5088","DOI":"10.1210\/clinem\/dgab259","volume":"106","author":"M Kuzma","year":"2021","unstructured":"Kuzma M, Vanuga P, Sagova I, Pavai D, Jackuliak P, Killinger Z, Binkley N, Winzenrieth R, Payer J (2021) Vertebral fractures occur despite control of Acromegaly and are predicted by cortical volumetric bone Mineral Density. J Clin Endocrinol Metab 106(12):e5088\u2013e5096. https:\/\/doi.org\/10.1210\/clinem\/dgab259","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"1468_CR47","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1007\/s11102-017-0847-1","volume":"21","author":"L Dalle Carbonare","year":"2018","unstructured":"Dalle Carbonare L, Micheletti V, Cosaro E, Valenti MT, Mottes M, Francia G, Dav\u00ec MV (2018) Bone histomorphometry in acromegaly patients with fragility vertebral fractures. Pituitary 21(1):56\u201364. https:\/\/doi.org\/10.1007\/s11102-017-0847-1","journal-title":"Pituitary"},{"issue":"9","key":"1468_CR48","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1007\/s00198-023-06800-z","volume":"34","author":"H Kwon","year":"2023","unstructured":"Kwon H, Han KD, Kim BS, Moon SJ, Park SE, Rhee EJ, Lee WY (2023) Acromegaly and the long-term fracture risk of the vertebra and hip: a national cohort study. Osteoporos Int 34(9):1591\u20131600. https:\/\/doi.org\/10.1007\/s00198-023-06800-z","journal-title":"Osteoporos Int"},{"issue":"6","key":"1468_CR49","doi-asserted-by":"publisher","first-page":"690","DOI":"10.3803\/EnM.2023.1782","volume":"38","author":"J Kim","year":"2023","unstructured":"Kim J, Hong N, Choi J, Moon JH, Kim EH, Lee EJ, Kim SG, Ku CR (2023) Increased risk of hip fracture in patients with acromegaly: a Nationwide Cohort Study in Korea. Endocrinol Metab (Seoul) 38(6):690\u2013700. https:\/\/doi.org\/10.3803\/EnM.2023.1782","journal-title":"Endocrinol Metab (Seoul)"},{"issue":"2","key":"1468_CR50","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.bone.2006.02.005","volume":"39","author":"A Angeli","year":"2006","unstructured":"Angeli A, Guglielmi G, Dovio A, Capelli G, de Feo D, Giannini S, Giorgino R, Moro L, Giustina A (2006) High prevalence of asymptomatic vertebral fractures in post-menopausal women receiving chronic glucocorticoid therapy: a cross-sectional outpatient study. Bone 39(2):253\u2013259. https:\/\/doi.org\/10.1016\/j.bone.2006.02.005","journal-title":"Bone"},{"issue":"5","key":"1468_CR51","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1007\/s11102-022-01252-w","volume":"25","author":"S Frara","year":"2022","unstructured":"Frara S, di Filippo L, Doga M, Loli P, Casanueva FF, Giustina A (2022) Novel approaches to bone comorbidity in Cushing\u2019s disease: an update. Pituitary 25(5):754\u2013759. https:\/\/doi.org\/10.1007\/s11102-022-01252-w","journal-title":"Pituitary"},{"key":"1468_CR52","doi-asserted-by":"publisher","unstructured":"Pedersini R, Amoroso V, Maffezzoni F, Gallo F, Turla A, Monteverdi S, Ardine M, Ravanelli M, Vassalli L, Rodella F, Formenti AM, Dalla Volta A, Simoncini EL, Giustina A, Maroldi R, Berruti A (2019) Association of Fat Body Mass with Vertebral fractures in Postmenopausal Women with early breast Cancer undergoing adjuvant aromatase inhibitor therapy. JAMA Netw Open 2(9). https:\/\/doi.org\/10.1001\/jamanetworkopen.2019.11080. e1911080","DOI":"10.1001\/jamanetworkopen.2019.11080"},{"issue":"4","key":"1468_CR53","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1016\/j.bone.2009.06.006","volume":"45","author":"T Mancini","year":"2009","unstructured":"Mancini T, Mazziotti G, Doga M, Carpinteri R, Simetovic N, Vescovi PP, Giustina A (2009) Vertebral fractures in males with type 2 diabetes treated with rosiglitazone. Bone 45(4):784\u2013788. https:\/\/doi.org\/10.1016\/j.bone.2009.06.006","journal-title":"Bone"},{"issue":"3","key":"1468_CR54","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1007\/s12020-011-9586-7","volume":"41","author":"C Torti","year":"2012","unstructured":"Torti C, Mazziotti G, Soldini PA, Foca E, Maroldi R, Gotti D, Carosi G, Giustina A (2012) High prevalence of radiological vertebral fractures in HIV-infected males. Endocrine 41(3):512\u2013517. https:\/\/doi.org\/10.1007\/s12020-011-9586-7","journal-title":"Endocrine"},{"issue":"2","key":"1468_CR55","doi-asserted-by":"publisher","first-page":"e602","DOI":"10.1210\/clinem\/dgaa738","volume":"106","author":"L di Filippo","year":"2021","unstructured":"di Filippo L, Formenti AM, Doga M, Pedone E, Rovere-Querini P, Giustina A (2021) Radiological thoracic vertebral fractures are highly prevalent in COVID-19 and predict Disease outcomes. J Clin Endocrinol Metab 106(2):e602\u2013e614. https:\/\/doi.org\/10.1210\/clinem\/dgaa738","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"1468_CR56","doi-asserted-by":"publisher","first-page":"655","DOI":"10.3803\/EnM.2023.601","volume":"38","author":"A Giustina","year":"2023","unstructured":"Giustina A (2023) Acromegaly and bone: an update. Endocrinol Metab (Seoul) 38(6):655\u2013666. https:\/\/doi.org\/10.3803\/EnM.2023.601","journal-title":"Endocrinol Metab (Seoul)"},{"issue":"1","key":"1468_CR57","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1159\/000375450","volume":"103","author":"KM Claessen","year":"2016","unstructured":"Claessen KM, Mazziotti G, Biermasz NR, Giustina A (2016) Bone and Joint disorders in Acromegaly. Neuroendocrinology 103(1):86\u201395. https:\/\/doi.org\/10.1159\/000375450","journal-title":"Neuroendocrinology"},{"issue":"10","key":"1468_CR58","doi-asserted-by":"publisher","first-page":"3889","DOI":"10.1210\/jc.2009-0474","volume":"94","author":"N Sucunza","year":"2009","unstructured":"Sucunza N, Barahona MJ, Resmini E, Fernandez-Real JM, Ricart W, Farrerons J, Rodriguez Espinosa J, Marin AM, Puig T, Webb SM (2009) A link between bone mineral density and serum adiponectin and visfatin levels in acromegaly. J Clin Endocrinol Metab 94(10):3889\u20133896. https:\/\/doi.org\/10.1210\/jc.2009-0474","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"1468_CR59","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1359\/JBMR.050603","volume":"20","author":"S Bonadonna","year":"2005","unstructured":"Bonadonna S, Mazziotti G, Nuzzo M, Bianchi A, Fusco A, De Marinis L, Giustina A (2005) Increased prevalence of radiological spinal deformities in active acromegaly: a cross-sectional study in postmenopausal women. J Bone Miner Res 20(10):1837\u20131844. https:\/\/doi.org\/10.1359\/JBMR.050603","journal-title":"J Bone Min Res"},{"issue":"12","key":"1468_CR60","doi-asserted-by":"publisher","first-page":"4649","DOI":"10.1210\/jc.2008-0791","volume":"93","author":"G Mazziotti","year":"2008","unstructured":"Mazziotti G, Bianchi A, Bonadonna S, Cimino V, Patelli I, Fusco A, Pontecorvi A, De Marinis L, Giustina A (2008) Prevalence of vertebral fractures in men with acromegaly. J Clin Endocrinol Metab 93(12):4649\u20134655","journal-title":"J Clin Endocrinol Metabolism"},{"issue":"3","key":"1468_CR61","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1007\/s00223-020-00773-5","volume":"108","author":"K Mys","year":"2021","unstructured":"Mys K, Varga P, Stockmans F, Gueorguiev B, Neumann V, Vanovermeire O, Wyers CE, van den Bergh JPW, van Lenthe GH (2021) High-Resolution Cone-Beam Computed Tomography is a fast and promising technique to quantify bone microstructure and mechanics of the distal Radius. Calcif Tissue Int 108(3):314\u2013323. https:\/\/doi.org\/10.1007\/s00223-020-00773-5","journal-title":"Calcif Tissue Int"},{"issue":"1","key":"1468_CR62","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1111\/cen.14439","volume":"95","author":"M Calatayud","year":"2021","unstructured":"Calatayud M, Perez-Olivares Martin L, Librizzi MS, Lora Pablos D, Mendez G, Aramendi Ramos V, Diaz-Guerra MM, Hawkins G (2021) Trabecular bone score and bone mineral density in patients with long-term controlled acromegaly. Clin Endocrinol 95(1):58\u201364. https:\/\/doi.org\/10.1111\/cen.14439","journal-title":"Clin Endocrinol"},{"issue":"3","key":"1468_CR63","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1007\/s00198-015-3344-2","volume":"27","author":"AR Hong","year":"2016","unstructured":"Hong AR, Kim JH, Kim SW, Kim SY, Shin CS (2016) Trabecular bone score as a skeletal fragility index in acromegaly patients. Osteoporos Int 27(3):1123\u20131129. https:\/\/doi.org\/10.1007\/s00198-015-3344-2","journal-title":"Osteoporos Int"},{"issue":"8","key":"1468_CR64","doi-asserted-by":"publisher","first-page":"bvab090","DOI":"10.1210\/jendso\/bvab090","volume":"5","author":"E Sala","year":"2021","unstructured":"Sala E, Malchiodi E, Carosi G, Verrua E, Cairoli E, Ferrante E, Filopanti M, Eller-Vainicher C, Ulivieri FM, Spada A, Arosio M, Chiodini I, Mantovani G (2021) Spine bone texture assessed by trabecular bone score in active and controlled acromegaly: a prospective study. J Endocr Soc 5(8):bvab090. https:\/\/doi.org\/10.1210\/jendso\/bvab090","journal-title":"J Endocr Soc"},{"issue":"4","key":"1468_CR65","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1159\/000528199","volume":"113","author":"F Bioletto","year":"2023","unstructured":"Bioletto F, Barale M, Prencipe N, Berton AM, Parasiliti-Caprino M, Gasco V, Ghigo E, Procopio M, Grottoli S (2023) Trabecular bone score as an index of bone fragility in patients with acromegaly: a systematic review and Meta-analysis. Neuroendocrinology 113(4):395\u2013405. https:\/\/doi.org\/10.1159\/000528199","journal-title":"Neuroendocrinology"},{"key":"1468_CR66","doi-asserted-by":"publisher","unstructured":"Nazzari E, Casabella A, Paolino S, Campana C, Corica G, Nista F, Milioto A, Tagliafico A, Albertelli M, Boschetti M, Bagnasco M, Cutolo M, Ferone D, Gatto F (2022) Trabecular bone score as a Reliable measure of lumbar spine bone microarchitecture in Acromegalic patients. J Clin Med 11(21). https:\/\/doi.org\/10.3390\/jcm11216374","DOI":"10.3390\/jcm11216374"},{"issue":"1","key":"1468_CR67","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1007\/s11914-017-0346-3","volume":"15","author":"CMJ de Bakker","year":"2017","unstructured":"de Bakker CMJ, Tseng WJ, Li Y, Zhao H, Liu XS (2017) Clinical evaluation of bone strength and fracture risk. Curr Osteoporos Rep 15(1):32\u201342. https:\/\/doi.org\/10.1007\/s11914-017-0346-3","journal-title":"Curr Osteoporos Rep"},{"issue":"3","key":"1468_CR68","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1002\/jbmr.3901","volume":"35","author":"N Mikolajewicz","year":"2020","unstructured":"Mikolajewicz N, Bishop N, Burghardt AJ, Folkestad L, Hall A, Kozloff KM, Lukey PT, Molloy-Bland M, Morin SN, Offiah AC, Shapiro J, van Rietbergen B, Wager K, Willie BM, Komarova SV, Glorieux FH (2020) HR-pQCT measures of bone microarchitecture predict fracture: systematic review and Meta-analysis. J Bone Miner Res 35(3):446\u2013459. https:\/\/doi.org\/10.1002\/jbmr.3901","journal-title":"J Bone Min Res"},{"issue":"4","key":"1468_CR69","doi-asserted-by":"publisher","first-page":"1734","DOI":"10.1210\/jc.2012-4073","volume":"98","author":"M Madeira","year":"2013","unstructured":"Madeira M, Neto LV, de Paula Paranhos Neto F, Lima B, Carvalho de Mendon\u00e7a IC, Gadelha LM, Fleiuss de Farias MR (2013) Acromegaly has a negative influence on trabecular bone, but not on cortical bone, as assessed by high-resolution peripheral quantitative computed tomography. J Clin Endocrinol Metab 98(4):1734\u20131741","journal-title":"J Clin Endocrinol Metabolism"},{"key":"1468_CR70","doi-asserted-by":"publisher","first-page":"738895","DOI":"10.3389\/fendo.2021.738895","volume":"12","author":"L Duan","year":"2021","unstructured":"Duan L, Yang S, Wang LJ, Zhang Y, Li R, Yang H, Zhao Y, Du H, Zhai X, Gong F, Pan H, Zhu H, Xia W (2021) The negative impacts of acromegaly on bone microstructure not fully reversible. Front Endocrinol 12:738895. https:\/\/doi.org\/10.3389\/fendo.2021.738895","journal-title":"Front Endocrinol"},{"issue":"2","key":"1468_CR71","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1007\/s12020-016-1078-3","volume":"54","author":"F Maffezzoni","year":"2016","unstructured":"Maffezzoni F, Maddalo M, Frara S, Mezzone M, Zorza I, Baruffaldi F, Doglietto F, Mazziotti G, Maroldi R, Giustina A (2016) High-resolution-cone beam tomography analysis of bone microarchitecture in patients with acromegaly and radiological vertebral fractures. Endocrine 54(2):532\u2013542. https:\/\/doi.org\/10.1007\/s12020-016-1078-3","journal-title":"Endocrine"},{"issue":"4","key":"1468_CR72","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/s001980200030","volume":"13","author":"M Bolanowski","year":"2002","unstructured":"Bolanowski M, Jedrzejuk D, Milewicz A, Arkowska A (2002) Quantitative ultrasound of the heel and some parameters of bone turnover in patients with acromegaly. Osteoporos Int 13(4):303\u2013308. https:\/\/doi.org\/10.1007\/s001980200030","journal-title":"Osteoporos Int"},{"issue":"3","key":"1468_CR73","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.jocd.2007.03.103","volume":"10","author":"D Kastelan","year":"2007","unstructured":"Kastelan D, Dusek T, Kraljevic I, Polasek O, Perkovic Z, Kardum I, Giljevic Z, Jelcic J, Aganovic I, Korsic M (2007) Bone properties in patients with acromegaly: quantitative ultrasound of the heel. J Clin Densitom 10(3):327\u2013331. https:\/\/doi.org\/10.1016\/j.jocd.2007.03.103","journal-title":"J Clin Densitom"},{"issue":"2","key":"1468_CR74","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1210\/jcem.85.2.6363","volume":"85","author":"A Giustina","year":"2000","unstructured":"Giustina A, Barkan A, Casanueva FF, Cavagnini F, Frohman L, Ho K, Veldhuis J, Wass J, Von Werder K, Melmed S (2000) Criteria for cure of acromegaly: a consensus statement. J Clin Endocrinol Metab 85(2):526\u2013529. https:\/\/doi.org\/10.1210\/jcem.85.2.6363","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"1468_CR75","doi-asserted-by":"publisher","first-page":"3141","DOI":"10.1210\/jc.2009-2670","volume":"95","author":"A Giustina","year":"2010","unstructured":"Giustina A, Chanson P, Bronstein MD, Klibanski A, Lamberts S, Casanueva FF, Trainer P, Ghigo E, Ho K, Melmed S, Consensus A (2010) A consensus on criteria for cure of acromegaly. J Clin Endocrinol Metab 95(7):3141\u20133148. https:\/\/doi.org\/10.1210\/jc.2009-2670","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"1468_CR76","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1007\/BF03349183","volume":"29","author":"M Gola","year":"2006","unstructured":"Gola M, Bonadonna S, Mazziotti G, Amato G, Giustina A (2006) Resistance to somatostatin analogs in acromegaly: an evolving concept? J Endocrinol Invest 29(1):86\u201393. https:\/\/doi.org\/10.1007\/BF03349183","journal-title":"J Endocrinol Investig"},{"issue":"1","key":"1468_CR77","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s11102-015-0681-2","volume":"19","author":"A Giustina","year":"2016","unstructured":"Giustina A, Bevan JS, Bronstein MD, Casanueva FF, Chanson P, Petersenn S, Thanh XM, Sert C, Houchard A, Guillemin I, Melmed S, Group SI (2016) SAGIT(R): clinician-reported outcome instrument for managing acromegaly in clinical practice\u2013development and results from a pilot study. Pituitary 19(1):39\u201349. https:\/\/doi.org\/10.1007\/s11102-015-0681-2","journal-title":"Pituitary"},{"issue":"9","key":"1468_CR78","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1038\/s41574-018-0058-5","volume":"14","author":"S Melmed","year":"2018","unstructured":"Melmed S, Bronstein MD, Chanson P, Klibanski A, Casanueva FF, Wass JAH, Strasburger CJ, Luger A, Clemmons DR, Giustina A (2018) A Consensus Statement on acromegaly therapeutic outcomes. Nat Rev Endocrinol 14(9):552\u2013561. https:\/\/doi.org\/10.1038\/s41574-018-0058-5","journal-title":"Nat Rev Endocrinol"},{"issue":"2","key":"1468_CR79","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/s12020-023-03317-7","volume":"80","author":"A Giustina","year":"2023","unstructured":"Giustina A, di Filippo L, Uygur MM, Frara S (2023) Modern approach to resistant acromegaly. Endocrine 80(2):303\u2013307. https:\/\/doi.org\/10.1007\/s12020-023-03317-7","journal-title":"Endocrine"},{"issue":"6","key":"1468_CR80","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.1210\/jc.2008-1337","volume":"94","author":"A Bianchi","year":"2009","unstructured":"Bianchi A, Giustina A, Cimino V, Pola R, Angelini F, Pontecorvi A, De Marinis L (2009) Influence of growth hormone receptor d3 and full-length isoforms on biochemical treatment outcomes in acromegaly. J Clin Endocrinol Metab 94(6):2015\u20132022. https:\/\/doi.org\/10.1210\/jc.2008-1337","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"1468_CR81","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1007\/s11154-020-09588-z","volume":"21","author":"A Giustina","year":"2020","unstructured":"Giustina A, Barkhoudarian G, Beckers A, Ben-Shlomo A, Biermasz N, Biller B, Boguszewski C, Bolanowski M, Bollerslev J, Bonert V, Bronstein MD, Buchfelder M, Casanueva F, Chanson P, Clemmons D, Fleseriu M, Formenti AM, Freda P, Gadelha M, Geer E, Gurnell M, Heaney AP, Ho KKY, Ioachimescu AG, Lamberts S, Laws E, Losa M, Maffei P, Mamelak A, Mercado M, Molitch M, Mortini P, Pereira AM, Petersenn S, Post K, Puig-Domingo M, Salvatori R, Samson SL, Shimon I, Strasburger C, Swearingen B, Trainer P, Vance ML, Wass J, Wierman ME, Yuen KCJ, Zatelli MC, Melmed S (2020) Multidisciplinary management of acromegaly: a consensus. Rev Endocr Metab Disord 21(4):667\u2013678. https:\/\/doi.org\/10.1007\/s11154-020-09588-z","journal-title":"Reviews Endocr Metabolic Disorders"},{"issue":"3","key":"1468_CR82","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1016\/j.ecl.2020.05.010","volume":"49","author":"S Frara","year":"2020","unstructured":"Frara S, Rodriguez-Carnero G, Formenti AM, Martinez-Olmos MA, Giustina A, Casanueva FF (2020) Pituitary Tumors Centers of Excellence. Endocrinol Metab Clin North Am 49(3):553\u2013564. https:\/\/doi.org\/10.1016\/j.ecl.2020.05.010","journal-title":"Endocrinol Metab Clin North Am"},{"key":"1468_CR83","doi-asserted-by":"publisher","DOI":"10.1007\/s11102-024-01397-w","author":"A Giustina","year":"2024","unstructured":"Giustina A, Uygur MM, Frara S, Barkan A, Biermasz NR, Chanson P, Freda P, Gadelha M, Haberbosch L, Kaiser UB, Lamberts S, Laws E, Nachtigall LB, Popovic V, Reincke M, van der Lely AJ, Wass JAH, Melmed S, Casanueva FF (2024) Standards of care for medical management of acromegaly in pituitary tumor centers of excellence (PTCOE). Pituitary. https:\/\/doi.org\/10.1007\/s11102-024-01397-w","journal-title":"Pituitary"},{"issue":"5","key":"1468_CR84","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1007\/s11102-023-01345-0","volume":"26","author":"A Giustina","year":"2023","unstructured":"Giustina A, Uygur MM, Frara S, Barkan A, Biermasz NR, Chanson P, Freda P, Gadelha M, Kaiser UB, Lamberts S, Laws E, Nachtigall LB, Popovic V, Reincke M, Strasburger C, van der Lely AJ, Wass JAH, Melmed S, Casanueva FF (2023) Pilot study to define criteria for Pituitary Tumors Centers of Excellence (PTCOE): results of an audit of leading international centers. Pituitary 26(5):583\u2013596. https:\/\/doi.org\/10.1007\/s11102-023-01345-0","journal-title":"Pituitary"},{"issue":"5","key":"1468_CR85","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1007\/s11102-017-0838-2","volume":"20","author":"FF Casanueva","year":"2017","unstructured":"Casanueva FF, Barkan AL, Buchfelder M, Klibanski A, Laws ER, Loeffler JS, Melmed S, Mortini P, Wass J, Giustina A (2017) Criteria for the definition of Pituitary Tumor Centers of Excellence (PTCOE): a Pituitary Society Statement. Pituitary 20(5):489\u2013498. https:\/\/doi.org\/10.1007\/s11102-017-0838-2","journal-title":"Pituitary"},{"issue":"4","key":"1468_CR86","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1007\/s11154-020-09564-7","volume":"21","author":"P Mortini","year":"2020","unstructured":"Mortini P, Nocera G, Roncelli F, Losa M, Formenti AM, Giustina A (2020) The optimal numerosity of the referral population of pituitary tumors centers of excellence (PTCOE): a surgical perspective. Reviews Endocr Metabolic Disorders 21(4):527\u2013536. https:\/\/doi.org\/10.1007\/s11154-020-09564-7","journal-title":"Reviews Endocr Metabolic Disorders"},{"issue":"1","key":"1468_CR87","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1007\/s12020-017-1458-3","volume":"59","author":"P Mortini","year":"2018","unstructured":"Mortini P, Barzaghi LR, Albano L, Panni P, Losa M (2018) Microsurgical therapy of pituitary adenomas. Endocrine 59(1):72\u201381. https:\/\/doi.org\/10.1007\/s12020-017-1458-3","journal-title":"Endocrine"},{"issue":"5","key":"1468_CR88","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1210\/jc.2013-3757","volume":"99","author":"JD Carmichael","year":"2014","unstructured":"Carmichael JD, Bonert VS, Nuno M, Ly D, Melmed S (2014) Acromegaly clinical trial methodology impact on reported biochemical efficacy rates of somatostatin receptor ligand treatments: a meta-analysis. J Clin Endocrinol Metab 99(5):1825\u20131833. https:\/\/doi.org\/10.1210\/jc.2013-3757","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"1468_CR89","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1530\/EJE-20-0767","volume":"184","author":"S Chiloiro","year":"2021","unstructured":"Chiloiro S, Giampietro A, Mirra F, Donfrancesco F, Tartaglione T, Mattogno PP, Angelini F, Liverana L, Gessi M, Carmelo A, Rindi G, Giustina A, Fleseriu M, Pontecorvi A, De Marinis L, Bianchi A (2021) Pegvisomant and Pasireotide LAR as second line therapy in acromegaly: clinical effectiveness and predictors of response. Eur J Endocrinol\/Eur Fed Endocr Soc 184(2):217\u2013229. https:\/\/doi.org\/10.1530\/EJE-20-0767","journal-title":"Eur J Endocrinol\/Eur Fed Endocr Soc"},{"issue":"3","key":"1468_CR90","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1007\/s12020-021-02711-3","volume":"73","author":"S Chiloiro","year":"2021","unstructured":"Chiloiro S, Giampietro A, Visconti F, Rossi L, Donfrancesco F, Fleseriu CM, Mirra F, Pontecorvi A, Giustina A, Fleseriu M, De Marinis L, Bianchi A (2021) Glucose metabolism outcomes in acromegaly patients on treatment with pasireotide-LAR or pasireotide-LAR plus Pegvisomant. Endocrine 73(3):658\u2013666. https:\/\/doi.org\/10.1007\/s12020-021-02711-3","journal-title":"Endocrine"},{"issue":"17","key":"1468_CR91","doi-asserted-by":"publisher","first-page":"2433","DOI":"10.1517\/14656566.2013.847090","volume":"14","author":"A Giustina","year":"2013","unstructured":"Giustina A, Karamouzis I, Patelli I, Mazziotti G (2013) Octreotide for acromegaly treatment: a reappraisal. Expert Opin Pharmacother 14(17):2433\u20132447. https:\/\/doi.org\/10.1517\/14656566.2013.847090","journal-title":"Expert Opin Pharmacother"},{"issue":"6","key":"1468_CR92","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1007\/s40618-017-0614-1","volume":"40","author":"A Giustina","year":"2017","unstructured":"Giustina A, Arnaldi G, Bogazzi F, Cannavo S, Colao A, De Marinis L, De Menis E, Degli Uberti E, Giorgino F, Grottoli S, Lania AG, Maffei P, Pivonello R, Ghigo E (2017) Pegvisomant in acromegaly: an update. J Endocrinol Invest 40(6):577\u2013589. https:\/\/doi.org\/10.1007\/s40618-017-0614-1","journal-title":"J Endocrinol Investig"},{"issue":"1","key":"1468_CR93","doi-asserted-by":"publisher","first-page":"37","DOI":"10.17925\/EE.2024.20.1.9","volume":"20","author":"MM Uygur","year":"2024","unstructured":"Uygur MM, Villanova M, Frara S, Giustina A (2024) Clinical pharmacology of oral Octreotide capsules for the treatment of Acromegaly. touchREV Endocrinol 20(1):37\u201342. https:\/\/doi.org\/10.17925\/EE.2024.20.1.9","journal-title":"touchREV Endocrinol"},{"issue":"10","key":"1468_CR94","doi-asserted-by":"publisher","first-page":"e3785","DOI":"10.1210\/clinem\/dgaa526","volume":"105","author":"SL Samson","year":"2020","unstructured":"Samson SL, Nachtigall LB, Fleseriu M, Gordon MB, Bolanowski M, Labadzhyan A, Ur E, Molitch M, Ludlam WH, Patou G, Haviv A, Biermasz N, Giustina A, Trainer PJ, Strasburger CJ, Kennedy L, Melmed S (2020) Maintenance of Acromegaly Control in patients switching from Injectable somatostatin receptor ligands to oral Octreotide. J Clin Endocrinol Metab 105(10):e3785\u20133797. https:\/\/doi.org\/10.1210\/clinem\/dgaa526","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"1468_CR95","doi-asserted-by":"publisher","first-page":"2454","DOI":"10.1210\/jc.2017-00142","volume":"102","author":"A Giustina","year":"2017","unstructured":"Giustina A, Mazziotti G, Cannavo S, Castello R, Arnaldi G, Bugari G, Cozzi R, Ferone D, Formenti AM, Gatti E, Grottoli S, Maffei P, Maffezzoni F, Montini M, Terzolo M, Ghigo E (2017) High-dose and High-Frequency Lanreotide Autogel in Acromegaly: a Randomized, Multicenter Study. J Clin Endocrinol Metab 102(7):2454\u20132464. https:\/\/doi.org\/10.1210\/jc.2017-00142","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"1468_CR96","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1530\/EJE-09-0372","volume":"161","author":"A Giustina","year":"2009","unstructured":"Giustina A, Bonadonna S, Bugari G, Colao A, Cozzi R, Cannavo S, de Marinis L, Degli Uberti E, Bogazzi F, Mazziotti G, Minuto F, Montini M, Ghigo E (2009) High-dose intramuscular octreotide in patients with acromegaly inadequately controlled on conventional somatostatin analogue therapy: a randomised controlled trial. Eur J Endocrinol\/Eur Fed Endocr Soc 161(2):331\u2013338. https:\/\/doi.org\/10.1530\/EJE-09-0372","journal-title":"Eur J Endocrinol\/Eur Fed Endocr Soc"},{"issue":"5","key":"1468_CR97","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1007\/s11102-019-00977-5","volume":"22","author":"A Giustina","year":"2019","unstructured":"Giustina A, Bronstein MD, Chanson P, Petersenn S, Casanueva FF, Sert C, Houchard A, Melmed S (2019) Staging and managing patients with acromegaly in clinical practice: baseline data from the SAGIT(R) validation study. Pituitary 22(5):476\u2013487. https:\/\/doi.org\/10.1007\/s11102-019-00977-5","journal-title":"Pituitary"},{"key":"1468_CR98","doi-asserted-by":"publisher","unstructured":"Chiloiro S, Giampietro A, Frara S, Bima C, Donfrancesco F, Fleseriu CM, Pontecorvi A, Giustina A, Fleseriu M, De Marinis L, Bianchi A (2020) Effects of Pegvisomant and Pasireotide LAR on Vertebral fractures in Acromegaly resistant to first-generation SRLs. J Clin Endocrinol Metab 105(3). https:\/\/doi.org\/10.1210\/clinem\/dgz054","DOI":"10.1210\/clinem\/dgz054"},{"issue":"3","key":"1468_CR99","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/s11102-024-01398-9","volume":"27","author":"S Chiloiro","year":"2024","unstructured":"Chiloiro S, Giampietro A, Infante A, Mattogno PP, Lauretti L, Olivi A, De Marinis L, Pontecorvi A, Doglietto F, Bianchi A (2024) Bone health and skeletal fragility in second- and third-line medical therapies for acromegaly: preliminary results from a pilot single center experience. Pituitary 27(3):303\u2013309. https:\/\/doi.org\/10.1007\/s11102-024-01398-9","journal-title":"Pituitary"},{"issue":"4","key":"1468_CR100","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1007\/s11102-011-0293-4","volume":"14","author":"G Mazziotti","year":"2011","unstructured":"Mazziotti G, Mancini T, Mormando M, De Menis E, Bianchi A, Doga M, Porcelli T, Vescovi PP, De Marinis L, Giustina A (2011) High prevalence of radiological vertebral fractures in women with prolactin-secreting pituitary adenomas. Pituitary 14(4):299\u2013306. https:\/\/doi.org\/10.1007\/s11102-011-0293-4","journal-title":"Pituitary"},{"issue":"8","key":"1468_CR101","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1159\/000511811","volume":"111","author":"M Cellini","year":"2021","unstructured":"Cellini M, Biamonte E, Mazza M, Trenti N, Ragucci P, Milani D, Ferrante E, Rossini Z, Lavezzi E, Sala E, Mantovani G, Arosio M, Fornari M, Balzarini L, Lania AG, Mazziotti G (2021) Vertebral fractures Associated with spinal Sagittal Imbalance and Quality of Life in Acromegaly: a Radiographic Study with EOS 2D\/3D technology. Neuroendocrinology 111(8):775\u2013785. https:\/\/doi.org\/10.1159\/000511811","journal-title":"Neuroendocrinology"},{"key":"1468_CR102","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgad493","author":"S Chiloiro","year":"2023","unstructured":"Chiloiro S, Frara S, Gagliardi I, Bianchi A, Giampietro A, Medici M, Allora A, di Filippo L, Ambrosio MR, Pontecorvi A, Zatelli MC, De Marinis L, Giustina A (2023) Cholecalciferol use is associated with a decreased risk of incident morphometric vertebral fractures in acromegaly. J Clin Endocrinol Metab. https:\/\/doi.org\/10.1210\/clinem\/dgad493","journal-title":"J Clin Endocrinol Metab"},{"key":"1468_CR103","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgae390","author":"L di Filippo","year":"2024","unstructured":"di Filippo L, Giustina A (2024) Vitamin D deficiency and type 2 diabetes: the dangerous link between two modern pandemics. J Clin Endocrinol Metab. https:\/\/doi.org\/10.1210\/clinem\/dgae390","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"1468_CR104","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1007\/s11154-021-09693-7","volume":"22","author":"JP Bilezikian","year":"2021","unstructured":"Bilezikian JP, Formenti AM, Adler RA, Binkley N, Bouillon R, Lazaretti-Castro M, Marcocci C, Napoli N, Rizzoli R, Giustina A (2021) Vitamin D: dosing, levels, form, and route of administration: does one approach fit all? Rev Endocr Metab Disord 22(4):1201\u20131218. https:\/\/doi.org\/10.1007\/s11154-021-09693-7","journal-title":"Reviews Endocr Metabolic Disorders"},{"issue":"1","key":"1468_CR105","doi-asserted-by":"publisher","first-page":"88","DOI":"10.23736\/S2724-6507.22.03652-1","volume":"48","author":"R Burkhardt","year":"2023","unstructured":"Burkhardt R (2023) Vitamin D: review of physiology and clinical uses. Minerva Endocrinol (Torino) 48(1):88\u2013105. https:\/\/doi.org\/10.23736\/S2724-6507.22.03652-1","journal-title":"Minerva Endocrinol (Torino)"},{"issue":"1","key":"1468_CR106","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s12020-022-03208-3","volume":"79","author":"A Giustina","year":"2023","unstructured":"Giustina A, Bouillon R, Dawson-Hughes B, Ebeling PR, Lazaretti-Castro M, Lips P, Marcocci C, Bilezikian JP (2023) Vitamin D in the older population: a consensus statement. Endocrine 79(1):31\u201344. https:\/\/doi.org\/10.1007\/s12020-022-03208-3","journal-title":"Endocrine"},{"key":"1468_CR107","doi-asserted-by":"publisher","unstructured":"Mazziotti G, Battista C, Maffezzoni F, Chiloiro S, Ferrante E, Prencipe N, Grasso L, Gatto F, Olivetti R, Arosio M, Barale M, Bianchi A, Cellini M, Chiodini I, De Marinis L, Del Sindaco G, Di Somma C, Ferlin A, Ghigo E, Giampietro A, Grottoli S, Lavezzi E, Mantovani G, Morenghi E, Pivonello R, Porcelli T, Procopio M, Pugliese F, Scillitani A, Lania AG (2020) Treatment of Acromegalic Osteopathy in Real-life clinical practice: the BAAC (bone active drugs in acromegaly) study. J Clin Endocrinol Metab 105(9). https:\/\/doi.org\/10.1210\/clinem\/dgaa363","DOI":"10.1210\/clinem\/dgaa363"},{"key":"1468_CR108","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-024-02386-3","author":"S Grottoli","year":"2024","unstructured":"Grottoli S, Maffei P, Tresoldi AS, Granato S, Benedan L, Mariani P, Giustina A (2024) Insights from an Italian Delphi panel: exploring resistance to first-generation somatostatin receptor ligands and guiding second-line medical therapies in acromegaly management. J Endocrinol Invest. https:\/\/doi.org\/10.1007\/s40618-024-02386-3","journal-title":"J Endocrinol Investig"}],"container-title":["Pituitary"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-024-01468-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11102-024-01468-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-024-01468-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T01:01:56Z","timestamp":1757120516000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11102-024-01468-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,21]]},"references-count":108,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["1468"],"URL":"https:\/\/doi.org\/10.1007\/s11102-024-01468-y","relation":{},"ISSN":["1386-341X","1573-7403"],"issn-type":[{"value":"1386-341X","type":"print"},{"value":"1573-7403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,21]]},"assertion":[{"value":"19 October 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 August 2025","order":3,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":4,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Stefano Frara and Matteo Acanfora are co-first authors.","order":5,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"SF received research grant to Institution from Abiogen Pharma, consultancy and speaker fees from Ipsen, Novartis and Pfizer, took part in advisory boards from Recordati and Novo Nordisk. AG received grants\/scientific consultancy from Amolyt, Ipsen, Pfizer and Recordati. AG serves as Editor-in-Chief of Pituitary. The other Authors declare that they have no conflicts of interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}